EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Probiotic neoantigen delivery vectors for precision cancer immunotherapy

Andrew Redenti iD, Jongwon Im iD, Benjamin Redenti, Fangda Li, Mathieu Rouanne, Zeren Sheng, William Sun, Candice R Gurbatri, Shunyu Huang, Meghna Komaranchath iD, YoungUk Jang iD, Jaeseung Hahn und 5 weitere

Nature · 14.11.2024 · 635 (8038) · 453-461

DOI: 10.1038/s41586-024-08033-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nature, online erschienen am 16.10.2024. Verfasst von Andrew Redenti und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology & Immunology, Vagelos College of Physicians and Surgeons of Columbia University, New York, NY, USA. Hauptthemen laut MEDLINE: Antigens, Neoplasm, Cancer Vaccines, Epitopes, Escherichia coli. Die Arbeit wurde bisher 206-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antigens, NeoplasmCancer VaccinesEpitopesEscherichia coliImmunotherapyNeoplasmsPrecision MedicineProbioticsAnimalsFemaleHumansMiceCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCell Line, TumorCross-PrimingDendritic CellsKiller Cells, NaturalMice, Inbred C57BLNeoplasm MetastasisPhagocytosis

Substanzen

Antigens, NeoplasmCancer VaccinesEpitopes

Autor:innen und Institutionen

  • Department of Microbiology & Immunology, Vagelos College of Physicians and Surgeons of Columbia University, New York, NY, USA.
  • Department of Biomedical Engineering, Columbia University, New York, NY, USA.
  • Department of Biomedical Engineering, Columbia University, New York, NY, USA. td2506@columbia.edu.
  • Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA. td2506@columbia.edu.
  • Data Science Institute, Columbia University, New York, NY, USA. td2506@columbia.edu.
  • Department of Microbiology & Immunology, Vagelos College of Physicians and Surgeons of Columbia University, New York, NY, USA. na2697@cumc.columbia.edu.

ORCID-Profile: Andrew Redenti, Jongwon Im, Meghna Komaranchath, YoungUk Jang, Tal Danino, Nicholas Arpaia

Förderung

  • NCI NIH HHS

Zitieren

APA

Redenti, A., Im, J., Redenti, B., Li, F., Rouanne, M., Sheng, Z., Sun, W., Gurbatri, C. R., Huang, S., Komaranchath, M., Jang, Y., Hahn, J., Ballister, E. R., Vincent, R. L., Vardoshivilli, A., Danino, T., & Arpaia, N. (2024). Probiotic neoantigen delivery vectors for precision cancer immunotherapy. Nature, 635(8038), 453-461. https://doi.org/10.1038/s41586-024-08033-4

Vancouver

Redenti A, Im J, Redenti B, Li F, Rouanne M, Sheng Z, et al. Probiotic neoantigen delivery vectors for precision cancer immunotherapy. Nature. 2024;635(8038):453-461. doi:10.1038/s41586-024-08033-4

BibTeX
@article{Redenti2024,
  author = {Redenti, Andrew and Im, Jongwon and Redenti, Benjamin and Li, Fangda and Rouanne, Mathieu and Sheng, Zeren and Sun, William and Gurbatri, Candice R and Huang, Shunyu and Komaranchath, Meghna and Jang, YoungUk and Hahn, Jaeseung and Ballister, Edward R and Vincent, Rosa L and Vardoshivilli, Ana and Danino, Tal and Arpaia, Nicholas},
  title = {Probiotic neoantigen delivery vectors for precision cancer immunotherapy},
  journal = {Nature},
  year = {2024},
  volume = {635},
  number = {8038},
  pages = {453--461},
  doi = {10.1038/s41586-024-08033-4}
}
Kostenlos starten →